股本结构
单位：万股
| 公告日期 | 2024-03-07 | 2024-03-07 | 2024-03-07 | 2023-11-09 | 2023-11-09 | 2023-08-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 11303.87 | 11265.17 | 11239.95 | 11231.20 | 11231.20 | 11222.33 |
| 普通股本 | 11303.87 | 11265.17 | 11239.95 | 11231.20 | 11231.20 | 11222.33 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-09 | 2024-03-01 | 2023-12-31 | 2023-11-01 | 2023-09-30 | 2023-08-01 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-07 | 11303.87 | 未披露 | 定期报告 | 2024-04-09 |
| 2024-03-07 | 11265.17 | 未披露 | 定期报告 | 2024-03-01 |
| 2024-03-07 | 11239.95 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2023-12-31 |
| 2023-11-09 | 11231.20 | 未披露 | 定期报告 | 2023-11-01 |
| 2023-11-09 | 11231.20 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2023-09-30 |
| 2023-08-10 | 11222.33 | 未披露 | 定期报告 | 2023-08-01 |
| 2023-05-01 | 11195.59 | 未披露 | 定期报告 | 2023-04-14 |
| 2023-05-11 | 11195.59 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2023-03-31 |
| 2023-03-07 | 11181.01 | 未披露 | 定期报告 | 2023-03-01 |
| 2023-03-07 | 11149.28 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Vesting of restricted stock units
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2022-12-31 |
| 2022-11-23 | 10984.05 | 未披露 |
更多>>
Common stock offered 26,320,000 shares by the company
|
2022-11-23 |
| 2022-11-10 | 8352.05 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units and exercise of options
Issuance of common stock under employee stock purchase plan
|
2022-09-30 |
| 2022-08-11 | 8327.75 | 未披露 | 定期报告 | 2022-08-11 |
| 2022-08-11 | 8304.44 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units and exercise of options
|
2022-06-30 |
| 2022-04-26 | 8268.10 | 未披露 | 定期报告 | 2022-04-21 |
| 2022-03-08 | 8241.81 | 未披露 | 定期报告 | 2022-03-01 |
| 2022-03-08 | 8223.89 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Vesting of restricted stock units
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2021-12-31 |
| 2021-11-18 | 7844.96 | 未披露 |
更多>>
1.Common stock offered by company 25,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 53,449,567 shares of common stock outstanding as of September 30, 2021.
|
2021-11-18 |
| 2021-11-15 | 5344.96 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Vesting of restricted stock units
Exercise of common stock options
|
2021-09-30 |
| 2021-08-11 | 5330.90 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-08-11 | 5328.51 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
|
2021-06-30 |
| 2021-05-05 | 5311.26 | 未披露 |
更多>>
From December 31, 2020 to April 14, 2021
Vesting of restricted stock units
|
2021-04-14 |
| 2021-03-03 | 5294.59 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Issuance of common stock under employee stock purchase plan
Exercise of common stock options
Sale of common stock, net of offering costs
Issuance of common stock in connection with Pharmakon Amendment
|
2020-12-31 |
| 2020-11-05 | 5208.06 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of common stock options
Sale of common stock, net of offering costs
Issuance of common stock in connection with Pharmakon Amendment
|
2020-09-30 |
| 2020-08-18 | 5199.23 | 未披露 |
更多>>
1.Common stock offered by the company 6,000,000 shares.
2.Unless otherwise indicated, the number of shares of common stock to be outstanding after this offering is based on 45,992,273 shares of common stock outstanding as of June 30, 2020.
|
2020-08-18 |
| 2020-08-04 | 4599.23 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2020-06-30 |
| 2020-03-05 | 4590.62 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2019-12-31 |
| 2019-11-26 | 4584.17 | 未披露 | 定期报告 | 2019-11-25 |
| 2019-11-12 | 4158.17 | 未披露 | 定期报告 | 2019-11-08 |
| 2019-11-12 | 4148.84 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Exercise of common stock options
|
2019-09-30 |
| 2019-08-12 | 4143.59 | 未披露 | 定期报告 | 2019-08-09 |
| 2019-08-12 | 4143.09 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2019-06-30 |
| 2019-05-09 | 4126.44 | 未披露 |
更多>>
From December 31, 2018 to March 01, 2019
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
|
2019-03-01 |
| 2019-03-06 | 4122.75 | 未披露 |
更多>>
From December 31, 2017 to September 30, 2018
Sale of common stock, net of issuance costs
Exercise of common stock options
Exercise of warrants
Issuance of common stock under employee stock purchase plan
|
2018-09-30 |
| 2018-08-14 | 4122.06 | 未披露 | 定期报告 | 2018-08-03 |
| 2018-08-14 | 4112.16 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-06-11 | 4078.41 | 未披露 | 定期报告 | 2018-06-11 |
| 2018-05-14 | 3800.65 | 未披露 | 定期报告 | 2018-05-11 |
| 2018-05-14 | 3790.91 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-13 | 3786.57 | 未披露 | 定期报告 | 2018-03-01 |
| 2018-03-13 | 3780.26 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Conversion of convertible debt to Series C-2 preferred stock
Sale of Series D preferred stock, net of issuance costs
Reclassification of redeemable convertible preferred stock upon consummation of initial public offering
Sale of common stock upon consummation of initial public offering, net of issuance costs
Exercise of stock options, net of shares withheld for income taxes
|
2017-12-31 |
| 2017-11-27 | 3781.77 | 未披露 | 定期报告 | 2017-11-27 |
| 2017-10-13 | 3663.63 | 未披露 |
更多>>
1.Common stock offered by us:7,500,000 shares
2.the number of shares of our common stock to be outstanding after this offering is based on 29,136,273 shares of common stock outstanding as of June 30, 2017
3.a 2.8879-for-1 stock split of our common stock effected on October 10, 2017
|
2017-10-13 |
| 2017-11-27 | 406.77 | 868.06 |
更多>>
From December 31, 2016 To September 30, 2017
Conversion of convertible debt to Series C-2 preferred stock
Sale of Series D preferred stock, net of issuance costs
|
2017-09-30 |
| 2017-10-03 | 2913.63 | 未披露 | 定期报告 | 2017-06-30 |
From December 31,2022 to December 31,2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
From June 30, 2023 to September 30, 2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
From December 31, 2022 to March 31, 2023
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
From December 31, 2021 to December 31, 2022
Vesting of restricted stock units
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
Common stock offered 26,320,000 shares by the company
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units and exercise of options
Issuance of common stock under employee stock purchase plan
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units and exercise of options
From December 31, 2020 to December 31, 2021
Vesting of restricted stock units
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
1.Common stock offered by company 25,000,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 53,449,567 shares of common stock outstanding as of September 30, 2021.
From June 30, 2021 to September 30, 2021
Vesting of restricted stock units
Exercise of common stock options
From March 31, 2021 to June 30, 2021
Vesting of restricted stock units
Issuance of common stock under employee stock purchase plan
From December 31, 2020 to April 14, 2021
Vesting of restricted stock units
From December 31,2019 to December 31,2020
Issuance of common stock under employee stock purchase plan
Exercise of common stock options
Sale of common stock, net of offering costs
Issuance of common stock in connection with Pharmakon Amendment
From June 30, 2020 to September 30, 2020
Exercise of common stock options
Sale of common stock, net of offering costs
Issuance of common stock in connection with Pharmakon Amendment
1.Common stock offered by the company 6,000,000 shares.
2.Unless otherwise indicated, the number of shares of common stock to be outstanding after this offering is based on 45,992,273 shares of common stock outstanding as of June 30, 2020.
From March 31, 2020 to June 30, 2020
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
from December 31, 2018 to December 31, 2019
Sale of common stock, net of issuance costs
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
From June 30, 2019 to September 30, 2019
Exercise of common stock options
from March 31, 2019 to June 30,2019
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
From December 31, 2018 to March 01, 2019
Exercise of common stock options
Issuance of common stock under employee stock purchase plan
From December 31, 2017 to September 30, 2018
Sale of common stock, net of issuance costs
Exercise of common stock options
Exercise of warrants
Issuance of common stock under employee stock purchase plan
from December 31, 2016 to December 31, 2017
Conversion of convertible debt to Series C-2 preferred stock
Sale of Series D preferred stock, net of issuance costs
Reclassification of redeemable convertible preferred stock upon consummation of initial public offering
Sale of common stock upon consummation of initial public offering, net of issuance costs
Exercise of stock options, net of shares withheld for income taxes
1.Common stock offered by us:7,500,000 shares
2.the number of shares of our common stock to be outstanding after this offering is based on 29,136,273 shares of common stock outstanding as of June 30, 2017
3.a 2.8879-for-1 stock split of our common stock effected on October 10, 2017
From December 31, 2016 To September 30, 2017
Conversion of convertible debt to Series C-2 preferred stock
Sale of Series D preferred stock, net of issuance costs